je.st
news
Canaccord Genuity Reaffirms "Buy" Rating for Regeneron Pharmaceuticals
2015-05-26 01:13:12| Biotech - Topix.net
's stock had its "buy" rating reaffirmed by investment analysts at Canaccord Genuity in a note issued to investors on Thursday. They currently have a $460.00 price target on the biopharmaceutical company's stock.
Tags: buy
rating
pharmaceuticals
reaffirms
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||